NeuroOne Medical Technologies Corporation
NMTC
$0.652
$0.04858.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.75M | 3.45M | 3.92M | 3.73M | 2.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.75M | 3.45M | 3.92M | 3.73M | 2.82M |
| Cost of Revenue | 7.76M | 7.44M | 8.52M | 9.06M | 8.94M |
| Gross Profit | -2.01M | -3.99M | -4.60M | -5.33M | -6.13M |
| SG&A Expenses | 7.77M | 7.90M | 7.64M | 7.62M | 7.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.00M | -- | -- | -- | -- |
| Total Operating Expenses | 12.54M | 15.34M | 16.16M | 16.68M | 16.38M |
| Operating Income | -6.79M | -11.89M | -12.24M | -12.95M | -13.56M |
| Income Before Tax | -7.19M | -12.32M | -12.10M | -12.80M | -13.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.19 | -12.32 | -12.10 | -12.80 | -13.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.19M | -12.32M | -12.10M | -12.80M | -13.47M |
| EBIT | -6.79M | -11.89M | -12.24M | -12.95M | -13.56M |
| EBITDA | -6.53M | -11.64M | -11.99M | -12.71M | -13.34M |
| EPS Basic | -0.27 | -0.46 | -0.49 | -0.59 | -0.69 |
| Normalized Basic EPS | -0.17 | -0.29 | -0.31 | -0.37 | -0.43 |
| EPS Diluted | -0.27 | -0.46 | -0.49 | -0.59 | -0.69 |
| Normalized Diluted EPS | -0.17 | -0.29 | -0.31 | -0.37 | -0.43 |
| Average Basic Shares Outstanding | 113.91M | 107.07M | 99.52M | 89.75M | 80.25M |
| Average Diluted Shares Outstanding | 113.95M | 107.07M | 99.52M | 89.75M | 80.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |